Researchers from the Regional Centre for Biotechnology, Faridabad, found that removing the slow myosin heavy chain protein (a cell structural protein) in mice causes severe muscle weakness and type 2 diabetes by 6 months of age. The study reveals a direct molecular link between muscle health and whole-body blood sugar control, opening doors for new therapies and preventive health care.